527 related articles for article (PubMed ID: 38348027)
1. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.
Li D; Cao D; Sun Y; Cui Y; Zhang Y; Jiang J; Cao X
Front Immunol; 2024; 15():1331641. PubMed ID: 38348027
[TBL] [Abstract][Full Text] [Related]
2. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
4. Choline metabolism reprogramming mediates an immunosuppressive microenvironment in non-small cell lung cancer (NSCLC) by promoting tumor-associated macrophage functional polarization and endothelial cell proliferation.
Xiao B; Li G; Gulizeba H; Liu H; Sima X; Zhou T; Huang Y
J Transl Med; 2024 May; 22(1):442. PubMed ID: 38730286
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
Wang Y; Wang D; Yang L; Zhang Y
Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
7. Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy.
Li L; Ma SR; Yu ZL
Cell Oncol (Dordr); 2024 Apr; 47(2):415-428. PubMed ID: 37776422
[TBL] [Abstract][Full Text] [Related]
8. Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment.
Cheng H; Zheng Y
PeerJ; 2024; 12():e16825. PubMed ID: 38239299
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophages: new insights on their metabolic regulation and their influence in cancer immunotherapy.
Xiao L; Wang Q; Peng H
Front Immunol; 2023; 14():1157291. PubMed ID: 37426676
[TBL] [Abstract][Full Text] [Related]
10. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
[TBL] [Abstract][Full Text] [Related]
11. Green Tea Polyphenol EGCG Attenuates MDSCs-mediated Immunosuppression through Canonical and Non-Canonical Pathways in a 4T1 Murine Breast Cancer Model.
Xu P; Yan F; Zhao Y; Chen X; Sun S; Wang Y; Ying L
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32290071
[TBL] [Abstract][Full Text] [Related]
12. The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma.
Li D; Cao D; Cui Y; Sun Y; Jiang J; Cao X
Front Pharmacol; 2023; 14():1201085. PubMed ID: 37292151
[TBL] [Abstract][Full Text] [Related]
13. Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy.
Wang Y; Johnson KCC; Gatti-Mays ME; Li Z
J Hematol Oncol; 2022 Aug; 15(1):118. PubMed ID: 36031601
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of green tea and epigallocatechin-3-gallate in a LPS-induced systemic inflammation model.
Azambuja JH; Mancuso RI; Via FID; Torello CO; Saad STO
J Nutr Biochem; 2022 Mar; 101():108920. PubMed ID: 34875388
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment.
Ma G; Zhang Z; Li P; Zhang Z; Zeng M; Liang Z; Li D; Wang L; Chen Y; Liang Y; Niu H
Cell Commun Signal; 2022 Jul; 20(1):114. PubMed ID: 35897036
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin‑3‑gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancer‑associated fibroblasts.
Chen S; Nishi M; Morine Y; Shimada M; Tokunaga T; Kashihara H; Takasu C; Yamada S; Wada Y
Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 35029285
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells.
Ohga N; Hida K; Hida Y; Muraki C; Tsuchiya K; Matsuda K; Ohiro Y; Totsuka Y; Shindoh M
Cancer Sci; 2009 Oct; 100(10):1963-70. PubMed ID: 19650861
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion.
Yan L; Wu M; Wang T; Yuan H; Zhang X; Zhang H; Li T; Pandey V; Han X; Lobie PE; Zhu T
Cancer Res; 2024 Apr; 84(8):1270-1285. PubMed ID: 38335272
[TBL] [Abstract][Full Text] [Related]
19. Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy.
Clappaert EJ; Murgaski A; Van Damme H; Kiss M; Laoui D
Front Immunol; 2018; 9():2250. PubMed ID: 30349530
[TBL] [Abstract][Full Text] [Related]
20. The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer.
Yang L; Zhang W; Chopra S; Kaur D; Wang H; Li M; Chen P; Zhang W
Curr Drug Targets; 2020; 21(11):1099-1104. PubMed ID: 32364072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
